Laura Joszt, MA, is a vice president of content at MJH Life Sciences® and oversees Formulary Watch®, Managed Healthcare Executive®, The American Journal of Managed Care®, The Center for Biosimilars®, and Pharmacy Times®.
She has been with MJH Life Sciences® since 2011. She has an MA in business and economic reporting from New York University.
You can reach her at firstname.lastname@example.org or you can connect with her on LinkedIn or Twitter.
Employers Face Barriers With Adopting BiosimilarsMarch 1st 2022
Despite the promise of savings billions of dollars in the United States, adoption of biosimilars has been slow. A roundtable discussion among employers highlighted some of the barriers, including formulary design and drug pricing and rebates.